Insider Trading & Ownership - Carter Percy H.

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Carter Percy H.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2024-03-07
Sale
2024-03-11
6:19 pm
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
2,286$90.69$207,31748,331
(Direct)
View
2023-06-05
Sale
2023-06-07
7:52 pm
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
2,307$52.06$120,10238,117
(Direct)
View
2023-03-06
Sale
2023-03-08
9:29 pm
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
761$45.69$34,76940,424
(Direct)
View
2022-06-06
Sale
2022-06-08
4:05 pm
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
1,908$59.76$114,02228,685
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-03-01
Option Award
2024-03-06
4:16 pm
N/A
2034-03-01
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
37,500$075,617
(Direct)
View
2023-03-01
Option Award
2023-03-03
8:16 pm
N/A
2033-03-01
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
37,500$066,185
(Direct)
View
2022-03-01
Option Award
2022-03-03
8:08 pm
N/A
2032-03-01
Blueprint Medicines CorpBPMCCarter Percy H.
CHIEF SCIENTIFIC OFFICER
26,250$048,093
(Direct)
View
2021-06-01
Option Award
2021-06-03
4:18 pm
N/A
2031-06-01
Blueprint Medicines CorpBPMCCarter Percy H.
Chief Scientific Officer
61,043$061,043
(Direct)
View